Article
Myeloid-derived suppressor cells and monocytes are biomarkers of the clinical phenotype and activity of psoriatic disease.
Rheumatology (Oxford, England) - 8 Jan 2026
Balderas-Miranda Jennifer T, Torres-Ruiz Jiram, Guaracha-Basañez Guillermo A, Alcalá-Carmona Beatriz, Reyna-Juárez Yatzil, Ostos-Prado María José, Juarez-Vega Guillermo, Mejía-Domínguez Nancy R, Méndez-Flores Silvia, Pascual Ramos Virgina, Gómez-Martín Diana
Abstract excerpt
OBJECTIVES: To assess the relation between the proportion of myeloid-derived suppressor cells (MDSCs), monocyte subsets, and the clinical phenotypes and disease activity of psoriatic disease (PsD), including psoriasis (PsO) and PsA. METHODS: We carried out a cross-sectional study including 47 patients with PsD and 10 age- and sex-paired healthy controls. Using multiparametric flow cytometry, we evaluated the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
